Recombinant enzyme replacement therapy for infantile-onset Pompe disease

被引:0
作者
Michio Hirano
机构
关键词
Enzyme Replacement Therapy; Fabry Disease; Pompe Disease; Lysosomal Storage Disease; Glycogen Storage Disease Type;
D O I
10.1007/s11910-008-0008-z
中图分类号
学科分类号
摘要
引用
收藏
页码:45 / 47
页数:2
相关论文
共 30 条
[1]  
Fukuda T.(2007)Acid alpha-glucosidase deficiency (Pompe disease) Curr Neurol Neurosci Rep 7 71-77
[2]  
Roberts A.(2004)Pompe disease in infants and children J Pediatr 144 S35-43
[3]  
Plotz P.H.(2004)Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice Mol Med 101 100-104
[4]  
Raben N.(2000)Recombinant human alpha-glucosidase from rabbit milk in Pompe patients Lancet 356 397-398
[5]  
Kishnani P.S.(2004)Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk Pediatrics 113 e448-457
[6]  
Howell R.R.(2005)Enzyme replacement therapy in classical infantile pompe disease: results of a tenmonth follow-up study Neuropediatrics 36 6-11
[7]  
Sly W.S.(2004)Enzyme replacement therapy in late-onset Pompe’s disease: a three-year follow-up Ann Neurol 55 495-502
[8]  
Van den Hout H.(2001)Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial Genet Med 3 132-138
[9]  
Reuser A.J.(2006)Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease J Pediatr 149 89-97
[10]  
Vulto A.G.(2007)Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease Neurology 68 99-109